Brief: Botanix Pharmaceuticals Says HY Loss From Cont Ops After Tax Attributable A$4.6 Mln
28/02/2023 07:08
Feb 28 (Reuters) - Botanix Pharmaceuticals Ltd BOT.AX :
* HY LOSS FROM CONTINUING OPERATIONS AFTER TAX ATTRIBUTABLE
A$4.6
MILLION VERSUS LOSS OF A$6.5 MILLION
Source text for Eikon: ID:nASX1Q25g5
Further company coverage: BOT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Botanix Pharmaceuticals
See all newsBrief: Botanix Pharmaceuticals Receives Notice Of Allowance For Additional US Patent Covering Sofdra Drug Substance
Brief: Botanix Pharmaceuticals Appoints Paul Seaback As Chief Operating Officer
Brief: Botanix Pharmaceuticals Reaches Term Sheet Agreement With Second API Supplier
Botanix Pharmaceuticals jumps on supply agreement with PPL Pharma Solutions
Brief: Botanix Pharmaceuticals Posts HY Loss Attributable A$33.2 Million